|
1 |
02 12 2024 |
Industry apprehends lack of coordination may stall envisaged growth in medical devices sector |
PHARMABIZ |
India |
|
2 |
02 12 2024 |
Suven Pharmaceuticals Ltd Surges 4.23% |
Business Standrad |
India |
|
3 |
02 12 2024 |
Biocon Biologics receives FDA approval for biosimilar YESINTEK |
Express Pharma |
India |
|
4 |
02 12 2024 |
All remaining service areas of Kerala drug control department to become online very soon |
PHARMABIZ |
India |
|
5 |
02 12 2024 |
DGTR terminates anti-dumping investigation on mono ethylene glycol imports |
PHARMABIZ |
India |
|
6 |
30 11 2024 |
Exports of India's med-tech industry could reach USD 20 bn by 2030; sector needs govt support: CII |
Health world (Economic Times) |
India |
|
7 |
30 11 2024 |
FICCI seeks govt nod to restart import of pre-owned expensive medical equipment |
Health world (Economic Times) |
India |
|
8 |
30 11 2024 |
Ayush packages not included in AB-PMJAY: Government |
Health world (Economic Times) |
India |
|
9 |
30 11 2024 |
WHO wants bird flu surveillance stepped up |
Health world (Economic Times) |
Switzerland |
|
10 |
30 11 2024 |
Maternal deaths in Ballari: CM orders suspension of Drugs Controller, blacklisting of pharma company |
The Hindu |
India |
|
11 |
30 11 2024 |
Serum to sell 40 per cent in pharma packaging JV to TPG Growth |
Financial Express |
India |
|
12 |
30 11 2024 |
India’s pharma sector set for rapid growth, 86 percent CXOs call for ecosystem collaboration: EY Parthenon-OPPI report |
Financial Express |
India |
|
13 |
30 11 2024 |
India takes centre-stage in clinical trials for HIV/AIDS drug |
PHARMABIZ |
India |
|
14 |
30 11 2024 |
Imports of surgicals grew 11.5 per cent in H1 FY25 |
PHARMABIZ |
India |
|
15 |
30 11 2024 |
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation |
PHARMABIZ |
India |
|
16 |
29 11 2024 |
Indian pharma looking at $4 bn market in 3 yrs from patent expiries |
Deccan Herald |
India |
|
17 |
29 11 2024 |
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World |
Business Standrad |
India |
|
18 |
29 11 2024 |
Janaushadhi Kendras to put pressure on retail medicine market trade margin : Pharma Secretry Arunish Chawla |
Live Mint |
India |
|
19 |
29 11 2024 |
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg |
PHARMABIZ |
India |
|
20 |
29 11 2024 |
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others |
Business Standrad |
India |
